Location History:
- Bad Nauheim, DE (2014)
- Bad Vilbel, DE (2011 - 2017)
Company Filing History:
6 out of 45 
2 out of 217 
2 out of 255 
Years Active: 2011-2017
Title: The Innovative Contributions of Elmar Kraus in Autoimmune Disease Treatments
Introduction
Elmar Kraus, an accomplished inventor based in Bad Vilbel, Germany, has made significant contributions to the field of pharmaceutical innovation. With eight patents to his name, he has focused primarily on developing treatments for autoimmune diseases, showcasing his commitment to improving patient outcomes through scientific advancements.
Latest Patents
Among his notable innovations are two key patents aimed at treating psoriasis and other autoimmune conditions. The first, titled "Method for treating psoriasis," involves a pharmaceutical composition that includes a pharmaceutically acceptable carrier and an agent capable of activating CD4+CD25+ regulatory T cells. This composition is designed to be administered to a subject at most every three days. The second patent, "Agent for treating disease," also provides a pharmaceutical composition for autoimmune diseases, containing an agent that activates the same regulatory T cells, with dosing parameters ranging from 10 mg to 200 mg.
Career Highlights
Elmar Kraus has had an impressive career, having worked with reputable companies in the pharmaceutical sector. He has gained valuable experience at Biotest AG and Fresenius Kabi Deutschland GmbH, where he has applied his innovative thinking and expertise to the development of new treatments. His work demonstrates not only his technical abilities but also his dedication to addressing challenging medical conditions through innovation.
Collaborations
Throughout his career, Kraus has collaborated with talented peers such as Christoph Bruecher and Frank Osterroth. These partnerships exemplify the collaborative spirit of the scientific community, where sharing knowledge and insights can lead to groundbreaking discoveries and advancements in medical treatments.
Conclusion
Elmar Kraus stands out as a notable inventor in the pharmaceutical industry, particularly for his advancements in the treatment of autoimmune diseases. His eight patents reflect a deep commitment to innovation and patient care. With continued efforts and collaboration, Kraus promises to contribute further to the evolving landscape of medical science.